chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This is a spontaneous report received from a contactable consumer or other non-HCP. A female patient received unknown dose number of BNT162B2 (Pfizer-BioNTech COVID-19 vaccine, batch/lot# unknown), single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications not reported. The patient developed illness, with outcome of unknown. A female friend of her grandson also got sick for 4 days after getting vaccinated. Clinical course: Reporter mentioned that one of her grandchildren also got the vaccine. She mentioned "it was like being hit by a mad truck," but she was okay in a few days. A female friend of her grandson also got sick for 4 days after getting vaccinated. Reporter stated their other grandson said her friend was sick for 4 days, but doesn't know she is reporting it. She wanted to be responsible and let know this happened. No follow-up attempts possible. Information about batch/lot number cannot be obtained. No further information expected.
Mononucleosis infectious Initial report received from a health care provider on 24/Mar/2006. A female patient (age not specified), had received an injection of Menactra, manufacturer sanofi pasteur, lot number not reported on an unspecified date. Route and site of administration were not reported. At an unspecified period of time following vaccination, the patient "tested positive for mono". Additional information was not provided. At the time of this report, the recovery was not reported.
I received 1st dose of the vaccine at 4:30pm on the 15th, felt well and at my baseline.  The morning of the 16th (~1030), I woke up with my face and cheeks swollen and mildly red.  I then took 50mg Benadryl and 10mg zyrtec, and iced my face (1 zyrtec in the morning, another at night).   I began to see improvement in my swelling.  The morning of the 17th I took another 50mg of Benadryl and my face is back to it's baseline.
A couple of days after receiving (09/15/22) the bivalent vaccine I developed loose stools which progressed into diarrhea. This chronic (diarrhea) condition has persisted for the last 3 weeks. Nothing seems to slow it down, let alone ameliorate it. I have tried Imodium, Pepto Bismol, diet, and am now adding Metamucil. Some of the data seems to concur that the Bivalent vaccine does cause chronic diarrhea. I there any solution to this problem or does my current medical condition have to run its course?
Patient was given vaccine 5/28/21 with no complaints. Presented back to the pharmacy 10/01/21 complaining of continued arm pain that started after immunization. States pain is relieved with IBUPROFEN, but returns after medication wears off. Hasn't seen a doctor for the problem. Instructed to go be seen by physician.
Severe left upper back pain, radiating around torso to left breast, rash appeared 10/08/2013-was diagnosed with shingles the same day, 10/08/2013.
itch; Red at injection site; Bruising; skin was a little more rough and more leathery than normal; skin was a little more rough and more leathery than normal; This is a spontaneous report from a contactable consumer (patient). A 78-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection), via an unspecified route of administration, on 01Feb2021 14:40 (Batch/lot number: EL9265), at age 78 years old, as dose 2, single, for COVID-19 immunisation, at a hospital. Relevant medical history and concomitant medications were not reported. Historical vaccine included BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection), received on 11Jan2021 (Batch/lot number: ELO142), at 78 years old, as dose 1 single, for COVID-19 immunisation after which the patient experienced rash at injection site, bruise, vaccination site pruritus, vaccination site erythema, vaccination site swelling and her skin was a little more rough and more leathery than normal. On an unspecified date, after the second vaccination, the patient experienced itch, red at injection site, bruising and her skin was a little more rough and more leathery than normal. The patient received an unspecified flu vaccine in Sep2021. No treatment was received for events itch, bruising, and skin was a little more rough and more leathery than normal. The outcome of bruising was not recovered. The outcome of the remaining events was unknown.  No follow-up attempts are possible. No further information is expected.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Additional Details: Patient received covid shot then proceeded to sit next to pharmacy. Patient fell off where she was sitting onto floor. Patient sat up after approximately two seconds after apparently passing out per patient. Provided patient with water and elevated legs. Patient reported she had felt extremely anxious about the vaccination and fell down due to anxiety. Patient reported a slight headache due to this as well. Patient denied feeling slowed or elevated heart rate.
This is a spontaneous report from a contactable nurse. A currently, 63-year-old female patient of an unspecified ethnicity received pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) (manufacturer not provided), via an unspecified route of administration from an unspecified date to an unspecified date at an unspecified dose for immunization and influenza vaccine (manufacturer not provided), via an unspecified route of administration from an unspecified date to an unspecified date at an unspecified dose for immunization. The patient's medical history included allergies to adhesive tape. Concomitant medications were not reported. On an unknown date, the patient experienced allergies to "pneumonia vaccines and influenza vaccines". The clinical outcome of the event, allergies to "pneumonia vaccines and influenza vaccines, was unknown. Pfizer is a marketing authorization holder of pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) in the reporter's country. This may be a duplicate report if another marketing authorization holder of pneumococcal 13-valent conjugate vaccine (diphtheria crm197 protein) has submitted the same report to the regulatory authorities.
It started off like little red freckles. One day they got extremely red and blotchy. They are mostly on my lower legs, but they have spread to the pubic area and lower stomach. I went to Urgent Care, and he indicated that it looks petechial. He advised me to see a dermatologist. The dermatologist confirmed it was petechial purpura. They took a biopsy since my bloodwork was fine. 2 weeks later I had another round of bloodwork and was diagnosed IGA vasculitis. They believe I caught a virus at some point and did not notice. The only treatment is to monitor with bloodwork quarterly to ensure I am healing and there are not any issues with my organs in my body.
tested positive/tested positive for the COVID-19 Virus; pepperoni tasting funny; This is a spontaneous report from a contactable consumer.   A 46-years-old male patient received bnt162b2 (Pfizer-BiONtech COVID-19 vaccine, formulation; solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 29Jan2021 (Batch/Lot Number: EL3247) as single dose  Covid-19 immunization.The patient medical history included Flublok Quadrivalent Vaccine on 20 an2021 ,9 days before his first COVID-19 Vaccine dose. He clarified he received the Flublok Quadrivalent Vaccine. He did not have the NDC, Lot and Expiration Date.The concomitant medications was not reported. The patient stated that received his first COVID-19 Vaccine dose on 29Jan2021, and then tested positive for the COVID-19 Virus on 09Feb2021. He said he wife had COVID-19 Virus symptoms the evening of 29Jan2021. He said he believes his wife was exposed to the COVID-19 Virus on Monday, 25Jan2021. He said he tested negative for the COVID-19 Virus on 03Feb2021, and then tested positive for the COVID-19 Virus on 09Feb2021. He said he tested negative, again, for the COVID-19 Virus on 14Feb2021. He clarified that all 3 COVID-19 Virus tests were 'rapid' tests (where the test is done 1'deep with 5 circles around) and the test results were back in a half hour. he had received a flu vaccine on 20Jan2021, 9 days before his first COVID-19 Vaccine dose. He clarified he received the Flublok Quadrivalent Vaccine. He did not have the NDC, Lot and Expiration Date. He considered 03Feb2021 his first day of minor symptoms. He clarified his only symptom was pepperoni tasting funny. He said his kids tested positive for the COVID-19 Virus on 03Feb2021. He was pretty sure of his COVID-19 Virus exposure time frame. He said his wife was exposed to the COVID-19 Virus when she had a hospital test done on 25Jan2021. He said his wife's COVID-19 Virus symptoms started on 29Jan2021. he is scheduled to get his second COVID-19 Vaccine dose on Friday, 19Feb2021. He said 19Feb2021 will be day 11 after testing positive for the COVID-19 Virus. He said he wanted to confirm if he should still get the second COVID-19 Vaccine dose on 19Feb2021, or if he needs to reschedule his second COVID-19 Vaccine dose to a later date. The patient underwent lab tests and procedures which included COVID-19 rapid POC test: negative on 03Feb2021, COVID-19 rapid POC test: positive on 09Feb2021, COVID-19 rapid POC test: negative on 14Feb2021.The outcome of the event tested positive/tested positive for the COVID-19 Virus was Recovered/Resolved on 14Feb2021 and outcome of pepperoni tasting funny was unknown.
A non-serious spontaneous report of administration of product to individuals over 49yo was received from a registered nurse/health professional concerning several individuals of unknown gender who were over the age of 49 years. Neither relevant medical history nor concomitant medications have been reported for these patients. On 19-Mar-2010, the patients received H1N1, Intranasal, for an unknown indication. There was no adverse event associated with this medication error therefore, treatment and reporter causality assessments are not applicable, and the event was considered resolved.
He got so dizzy; could hardly stand up; He had to hold the wall and lean on it in order to walk to the bathroom.He accidently ran into the wall.; He started to get chills really bad; get sick; He felt so weak; He started to get hot and sweaty; He started to get hot and sweaty; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 60 year-old male patient received bnt162b2 (BNT162B2), administration date 27Apr2021 16:40 (Lot number: EW0175) at the age of 60 years as dose 1, 0.3 ml single for covid-19 immunisation. Relevant medical history included: "COVID-19", start date: 19Mar2020 (unspecified if ongoing), notes: He had covid in Mar 2020. Covid whopped him back then. He was in the hospital for three months. He was hospitalized at Hospital. He had to fight for his life. He was very sick. Doctors had to do a lot of procedures to him in order to keep him alive. Concomitant medication(s) included: XARELTO taken for thrombosis. The following information was reported: ILLNESS (non-serious) with onset 28Apr2021 12:30, outcome "recovering", described as "get sick"; ASTHENIA (non-serious) with onset 28Apr2021 12:30, outcome "recovering", described as "He felt so weak"; CHILLS (non-serious) with onset 28Apr2021 13:00, outcome "recovered" (30Apr2021), described as "He started to get chills really bad"; FEELING HOT (non-serious), HYPERHIDROSIS (non-serious) all with onset 28Apr2021, outcome "recovering" and all described as "He started to get hot and sweaty"; DIZZINESS (non-serious) with onset 30Apr2021, outcome "recovering", described as "He got so dizzy"; BALANCE DISORDER (non-serious) with onset 30Apr2021, outcome "recovering", described as "could hardly stand up"; GAIT DISTURBANCE (non-serious) with onset 30Apr2021, outcome "recovering", described as "He had to hold the wall and lean on it in order to walk to the bathroom.He accidently ran into the wall."  Additional information: It was reported that the next day, 28Apr2021, about 12:30PM, he was getting dressed and he started to get sick. He felt so weak. About 30 minutes later, he started to get chills really bad. He felt like he was in a deep freezer. His chills lasted for a few hours. Then after that, he started to get hot and sweaty. He is getting better now. Early this morning, he got so dizzy. He could hardly stand up. He had to hold the wall and lean on it in order to walk to the bathroom. He accidently ran into the wall. The dizziness is lifting, it is getting better. Now whenever he lays down, sometimes he still gets dizzy, and sometimes he does not. He had covid in Mar2020. Covid whopped him back then. He was in the hospital for three months. He was hospitalized. He had to fight for his life. He was very sick. Doctors had to do a lot of procedures to him in order to keep him alive.  No follow-up attempts are possible. No further information is expected.
I started feeling tired the day after getting the vaccine. By 10/10/22 I was extremely exhausted and since I work in a medical office, I ask one of the doctors to check me out. He advised me to go get an EKG they said things look normal. I sat for three hours in the emergency room basically resting so I feel like I would get a normal reading. Once I left and walked up the hill to the truck to leave my heart started feeling overworked and exhausted. This is what my doctor could hear before I went to the emergency room. I did not go to work today, 10/11/22 as I am too exhausted and wore out to go in, my heart needs rest. Today I have had episode vomiting and diarrhea.
diabetes; This is a spontaneous report from a non-contactable consumer (patient's wife). A male patient of an unspecified age received BNT162B2, on Jan2021 (Batch/Lot number was not reported) as dose 1, single, then on Feb2021 (Batch/Lot number was not reported) as dose 2, single, via an unspecified route of administration for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient experienced diabetes on an unspecified date. The outcome of the event was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Since receiving the Pfizer booster, I have had constant constipation and irregular bowel movements.
Information has been received from a nurse concerning to unspecified number of patients (ages and genders not reported) who since 29-FEB-2016, were vaccinated with doses of VARIVAX (Merck) (Lot No. L028276, exp. 28-JUL-2017) (sites not reported), which were exposed to a temperature of -14.94C, for 6 hours. Vaccines had not been previous to temperature excursion. The reporter was not aware of any adverse effects. No PQC was involved. This report is linked to MARRS 1603USA003362 from the same reporter. Additional information has been requested.
Fever, Chills, Myalgia. It was reported that this female pt received vax in an unspecified deltoid and within 4 hours post vax, experienced a low-grade fever, chills and myalgia. She recovered.
chills; low grade fever; sever joint pain; burning scalp; paresthesias; This case was reported by a physician and described the occurrence of chills in a male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2020-2021 season) for prophylaxis.   On 2nd October 2020, the patient received the 1st dose of Shingrix and Influenza vaccine Quadrivalent 2020-2021 season. On an unknown date, 7 hrs after receiving Shingrix and Influenza vaccine Quadrivalent 2020-2021 season, the patient experienced chills, fever, joint pain, burning sensation scalp and paresthesia. On an unknown date, the outcome of the chills, fever, joint pain, burning sensation scalp and paresthesia were recovered/resolved.   It was unknown if the reporter considered the chills, fever, joint pain, burning sensation scalp and paresthesia to be related to Shingrix and Influenza vaccine Quadrivalent 2020-2021 season.  Additional details were provided as follows:  The age at vaccination was not reported. The patient suffered chills, low grade fever, severe joint pain and burning scalp paresthesia than began 7 hours after injection and peaked 12 hours after inject, resolving 3 hours after peak. He had an influenza injection at the same time. The reporter reported questions to VAERS site as, did dare to take the second vaccination in the series I should note, his symptoms were severe enough he almost went to the hospital because of the degree of pain.
Flu like symptoms; Fever; Feeling unwell; Headache; Hip and shoulder pain; Body ache; Hip and shoulder pain; Got lots of phlegm in throat and a cough; This is a spontaneous case, reported by other non-health professional to Med Communications (reference number: SEQ20-00435) and initially received on 29-Jan-2020, concerning a 59-year-old, female patient.   The patient's medical history was not reported. The patient's concomitant medications included Vitamin D (non-specified) for unknown indication.  On 26-Jan-2020, the patient was administered Flucelcax QIV [influenza vaccine, subunit influenza virus, vaccine polyvalent, dose: 0.5 mL, batch number: 261200, expiration date: 30-Jun-2020, route of administration and anatomical location: not reported] for influenza prophylaxis.  On the same day, immediately after vaccination, the patient started feeling unwell, got lots of phlegm and cough, and had to continually clear her throat.   On 27-Jan-2020, one day after vaccination, the patient developed fever, typical flu like symptoms, headache, body ache, hip and shoulder pain. The patient went to the pharmacist, and also to her physician, who tested her for the flu. The test results were negative. The patient stated that she was feeling a bit better.  At the time of the initial reporting, the outcome of all events was not reported.   The case was assessed as non-serious.  The reporter did not provide causality assessment.  Company comment: The patient experienced productive cough, pain, musculoskeletal pain, influenza like illness, headache, arthralgia, malaise and pyrexia after vaccination with the suspect product, Flucelcax QIV. Chronology is plausible. No medical history and diagnostic findings were provided. Considering all the above mentioned, causality between suspect product and the events is assessed as related.; Sender's Comments: The patient experienced productive cough, pain, musculoskeletal pain, influenza like illness, headache, arthralgia, malaise and pyrexia after vaccination with the suspect product, Flucelcax QIV. Chronology is plausible. No medical history and diagnostic findings were provided. Considering all the above mentioned, causality between suspect product and the events is assessed as related.
The patient received the first dose of the vaccine on 26Feb2021 and tested positive for covid on 08Mar2021.; This is a spontaneous report from a contactable pharmacist. This pharmacist reported similar events for two patients. This is 2nd of two reports. This case pertains to father case. A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number Unknown), via an unspecified route of administration on 26Feb2021 as single dose for covid-19 immunization. The patients medical history and concomitant medications were not reported. The reporter stated that patient and his daughter both received the first dose of the vaccine and then they both tested positive after it. The patients 14 day quarantine is up this coming Monday and his second dose is scheduled for next Friday. The patient received the first dose of the vaccine on 26Feb2021 and tested positive for covid on 08Mar2021. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 08Mar2021. The outcome of the event was reported as unknown.  No follow up attempts are possible; information on Lot/batch number cannot be obtained.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021304488 Different patient, same drug/event
17 year old was given Havrix Adult (Hep A) and the vaccine expiration date was 6/14/22
Patient lost consciousness and fell on the ground. She regained consciousness a few seconds later. She lost consciousness a second time and regained consciousness a few seconds later. She was nauseous and dizzy. She drank Coke and had slight improvement. Her blood pressure low. An ambulance was called and was taken to a nearby hospital.
Within 5 min. post injection patient had mood change, redness, swelling at injection site along with leg pain. We watched patient for a while and then he seemed okay. We sent home with instructions with parent to use benadryl and tylenol, cold compresses as needed. Mom agreed.
Respiratory distress with hypoxia, post vax. Viral vesicles on right buttocks; (Chickenpox type).
Felt fine on 12/30/2020.  Light-headed at 1100 on 12/31/2020.  Blood pressure 84/50.  Usually have normal or high B/P
Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; Administered vaccine that was stored at temperature between -80 degree F to -84 degree F; This spontaneous case was reported by a nurse and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 076C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Nov-2021 at 1:30 PM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 16-Nov-2021 at 1:30 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) and PRODUCT STORAGE ERROR (Administered vaccine that was stored at temperature between -80 degree F to -84 degree F) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided.  The vial undergone temperature excursions for 1 month. The vial was in frozen state at the time of the excursion (Vials in question stored in a super cold Freezer) and minimum reached temperatures was negative 82 degrees Fahrenheit. The patient was given dose from vial that was stored in an ultracold freezer which was colder than it should have been. The vial moved from freezer to refrigerator on 19-Nov-2021, it was a day when the Moderna COVID-19 vials went from the super cold freezer to the refrigerator. The vials were returned to the freezer/refrigerator or maintained at room temperature. The reporter stated that total 70 vials were still in the ultra-cold freezer and 8 vials were in the refrigerator. No vaccine state changes were noticed. The vaccine was never refrozen. None of the vials were punctured. No previous temperature excursions were reported.  No treatment medications were provided.   This case was linked to MOD-2021-402935 (Patient Link).
pt recvd vax;lab tests: titer of 1:16 which was not considered pos by lab;pt's titer was 0 at start